Be Familiar With Tenecteplase for Acute Ischemic Stroke

You’ll hear buzz about the thrombolytic tenecteplase (TNKase) now that it’s approved by Health Canada for treating acute ischemic stroke.

This adds to the uses for tenecteplase, since it’s already approved for patients with a heart attack caused by a blood clot.

Patients with an acute ischemic stroke usually receive alteplase to restore blood flow...as long as it’s within 4.5 hours of symptom onset and there are no contraindications, such as an intracranial bleed.